Identifying Predictive Factors for Metabolic Dysfunction-Related Steatotic Liver Disease (MASLD) in Patients with Cardio-Metabolic Risk: A Multicenter Cross-Sectional Analysis from North East Ethiopia - Takeaways - MDSpire

Identifying Predictive Factors for Metabolic Dysfunction-Related Steatotic Liver Disease (MASLD) in Patients with Cardio-Metabolic Risk: A Multicenter Cross-Sectional Analysis from North East Ethiopia

  • By

  • Getachew Bizuneh Aydagnuhm

  • Aklile Semu Tefera

  • Gebru Tesfaw Getahun

  • Ermiyas Endewunet Melaku

  • February 7, 2026

  • 0 min

Share

  • 1

    Metabolic dysfunction associated steatotic liver disease (MASLD) is a common chronic liver disease affecting over 30% of adults globally.

  • 2

    The study aimed to assess the prevalence and determinants of MASLD among individuals with cardio metabolic risk factors in Northeast Ethiopia.

  • 3

    A total of 384 adults with cardio metabolic risk factors were included in the study, excluding those with other liver disease causes.

  • 4

    Data collection involved interviews, clinical examinations, and laboratory tests to evaluate participants' health status and liver function.

  • 5

    Non-invasive methods like ultrasound and fibrosis scoring systems were utilized for the initial assessment and risk stratification of MASLD.

Original Source(s)

Identifying Predictive Factors for Metabolic Dysfunction-Related Steatotic Liver Disease (MASLD) in Patients with Cardio-Metabolic Risk: A Multicenter Cross-Sectional Analysis from North East Ethiopia

  • by Getachew Bizuneh Aydagnuhm, Aklile Semu Tefera, Gebru Tesfaw Getahun, Ermiyas Endewunet Melaku

  • February 7, 2026

Related Content

Proteins at the intersection of circadian rhythms and metabolic dysfunction-associated steatotic liver disease: an 18-protein panel as a novel predictive biomarker set

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis